What causes hyperparathyroidism to develop in the parathyroid glands? 

Hyperparathyroidism develops when the parathyroid glands lose their ability to regulate the secretion of parathyroid hormone in response to the body’s calcium needs. This disruption can occur for several reasons, ranging from structural changes within the glands themselves to external physiological pressures caused by other health conditions. Under normal circumstances, the parathyroid glands act as precise sensors that monitor blood calcium levels, but when they become overactive, they continuously signal the body to increase calcium levels beyond the healthy range. Identifying the specific cause of this overactivity is essential for determining whether the condition is a primary issue with the gland tissue or a secondary reaction to a systemic deficiency. 

What We’ll Discuss in This Article 

• The development of benign adenomas in primary hyperparathyroidism. 

• The role of glandular hyperplasia and its impact on hormone production. 

• How chronic kidney disease triggers secondary glandular overactivity. 

• The influence of long term vitamin D deficiency on parathyroid function. 

• Genetic and hereditary factors that predispose individuals to the condition. 

• The progression from secondary to tertiary hyperparathyroidism. 

Development of Benign Parathyroid Adenomas 

The most frequent cause of hyperparathyroidism is the development of a single benign tumour known as an adenoma on one of the four parathyroid glands. This occurs in approximately 80 to 85 percent of patients with the primary form of the disease. An adenoma develops when a single cell in the parathyroid gland undergoes a genetic change that causes it to multiply and grow into a small, non cancerous mass. This mass of tissue becomes autonomous, meaning it no longer follows the instructions of the body’s feedback loop and continues to pump out parathyroid hormone even when blood calcium levels are already high. 

While the exact reason these adenomas form is not always clear, research indicates that specific genetic mutations within the parathyroid cells play a significant role. These mutations interfere with the cell’s “calcium sensor,” making the gland believe that the body is permanently low in calcium. Consequently, the adenoma remains in a state of constant activity, leading to sustained hypercalcaemia. The Society for Endocrinology provides detailed clinical resources on how these glandular changes disrupt systemic mineral homeostasis and the standard diagnostic steps taken to identify them. 

Glandular Hyperplasia and Multi-Gland Disease 

In about 10 to 15 percent of cases, hyperparathyroidism is caused by a condition called hyperplasia, where all four parathyroid glands become enlarged. Unlike an adenoma, which is usually restricted to one gland, hyperplasia involves a general overgrowth of the parathyroid tissue across all glands. This leads to a collective overproduction of parathyroid hormone. Hyperplasia can occur spontaneously, but it is more frequently associated with specific inherited conditions that affect the endocrine system. 

Conditions such as Multiple Endocrine Neoplasia type 1 or type 2 are genetic syndromes where individuals are predisposed to developing tumours or overgrowth in multiple glands, including the parathyroid, pituitary, and pancreas. In these cases, the cause is a hereditary genetic mutation that is present from birth. The Genetic and Rare Diseases Information Centre, supported by public health frameworks, outlines how these hereditary mutations specifically target the parathyroid glands to cause early onset hyperparathyroidism. Early identification of these genetic markers is vital for the long term management of patients and their families. 

Secondary Causes: Chronic Kidney Disease 

Secondary hyperparathyroidism is caused by external factors that force the parathyroid glands to work harder to maintain calcium levels. The most prominent cause of this is chronic kidney disease. The kidneys are essential for maintaining mineral balance because they excrete excess phosphate and convert vitamin D into its active form. As kidney function declines, phosphate levels in the blood rise and active vitamin D levels fall, both of which cause blood calcium to drop. 

In response to this persistent low calcium, the parathyroid glands become hyperactive. They grow larger in an attempt to produce enough hormone to extract calcium from the bones to compensate for the kidney’s failure. This is a reactive process rather than a primary fault in the glands. The British Kidney Patient Association, now known as Kidney Care UK, offers extensive information on the link between renal failure and parathyroid overactivity, focusing on how managing phosphate intake can help stabilise the glands. 

Vitamin D Deficiency and Malabsorption 

Another common cause for the development of secondary hyperparathyroidism is severe and prolonged vitamin D deficiency. Vitamin D is necessary for the intestines to absorb calcium from the diet. If a person does not have enough vitamin D due to a lack of sunlight, poor diet, or a digestive condition that prevents absorption the body cannot get enough calcium from food. 

The parathyroid glands sense this deficiency and increase their hormone output to pull calcium from the skeletal reservoir instead. Over time, this constant stimulation can cause the glands to enlarge and remain in a state of overactivity. Conditions like celiac disease or Crohn’s disease, which affect the lining of the gut, are known contributors to this type of parathyroid stress. The Royal Pharmaceutical Society highlights the clinical necessity of correcting vitamin D levels to prevent the parathyroid glands from entering a state of chronic secondary overactivity. 

Progression to Tertiary Hyperparathyroidism 

In some cases, particularly in patients with long term kidney disease, the parathyroid glands can undergo a further change known as tertiary hyperparathyroidism. This happens after the glands have been in a state of secondary overactivity for many years. The constant stimulation causes the glands to become permanently enlarged and autonomous, similar to the adenomas seen in primary disease. 

At this stage, the glands no longer stop producing hormone even if the underlying cause is fixed, such as after a successful kidney transplant. The glands continue to produce high levels of hormone, leading to high blood calcium. This progression represents a shift from a reactive state to a permanent structural abnormality in the glandular tissue. It is a complex clinical scenario that often requires surgical intervention to remove the now autonomous glands. 

Type of Hyperparathyroidism	Primary Cause	Glandular Change
Primary	Benign Adenoma or Hyperplasia	Autonomous growth of gland tissue.
Secondary	Kidney Disease or Vitamin D Deficiency	Reactive enlargement due to low calcium.
Tertiary	Long term untreated secondary disease	Glands become permanently autonomous.

Conclusion 

Hyperparathyroidism develops due to either a structural fault within the parathyroid glands, such as a benign adenoma, or as a reactive response to systemic issues like kidney failure and vitamin D deficiency. Understanding whether the glands are the source of the problem or are simply responding to a deficiency is critical for choosing the right treatment. Most cases involve benign changes that can be successfully managed or cured. If you experience severe, sudden, or worsening symptoms, call 999 immediately. 

Authority Snapshot (E-E-A-T) 

The Medical Content Team at MyPatientAdvice provides evidence based health education strictly aligned with UK clinical standards. This article has been reviewed by Dr. Stefan Petrov, a UK-trained physician with experience in internal medicine, emergency care, and diagnostic procedures. All clinical information and recommendations are based on established guidelines from the NHS and the National Institute for Health and Care Excellence (NICE).